IBM’s New Breakthrough Technology That Fights Viruses
Viral infections are a large challenge for doctors and at times, they mutate to such an extent that it is not possible to cure them with drugs that are already available.
Viral infections are a large challenge for doctors and at times, they mutate to such an extent that it is not possible to cure them with drugs that are already available. Ebola and Zika are a risk to people around the world, but there is some good news. Singapore’s Institute of Bioengineering and Nanotechnology along with IBM Research have found a macromolecule that can use a triple play mechanism and prevent the spread of the most deadly infections.
By studying large multi-featured molecules, they believe the infections can be defeated. IBM Watson along with such breakthroughs that are imminent could bring forward further drug discoveries.
READ ALSO: Researches Turned Skin Cells into Heart and Brain Cells using Drugs
There are several specialised components in the macromolecule, and this results in the triple play action.
- Attraction – electrostatic interactions and hydrogen bonds attract the viruses’ proteins and stop it infecting healthy cells.
- Prevention – the sugar Mannose helps fight the infection by attaching to healthy immune cells and allowing then to flow freely.
- Neutralisation – the pH in the viral cell can be neutralised therefore stopping it reproducing.
Lead researcher James Hedrick is excited about the events that will come about as a result of this discovery and is hoping that there can be a collaboration with Universities to find more applications yet.
IBM will be able to advance this research yet further and thanks to cognitive computing, should be able to find clinical trials for patients ensuring that more people receive the help that they need.
Related Coverage
- Artificial Intelligence Genomics Company Invests Heavily in Drugs
- Virtual Reality Crime Scenes Could be on Their Way to Courtrooms Soon
- UM Solar Car Race Team Wants to Win The American Solar Challenge With Novum
- New CERN Particle Accelerator has Multiple Uses
- Breakthrough IBM Z Mainframe Promises to Stop Data Theft
Don't miss new tech stories on Google
Add TrendinTech once in the Google app and our stories appear in your news suggestions.
Yusuf Demir
Yusuf Demir is the Cloud & Software Reporter at TrendinTech, where he covers cloud infrastructure, enterprise platforms, developer tools and the digital transformation of businesses in the UK and the United States. He previously reported on enterprise technology for The Register in London and covered the cloud and SaaS beat for TechCrunch, following the competition between AWS, Microsoft Azure and Google Cloud, the open source licensing disputes and the rise of Kubernetes. Yusuf holds an MEng in Computing from Imperial College London and speaks regularly at KubeCon and AWS re:Invent, where he moderates conversations with engineers and chief technology officers. He is most interested in the gap between vendor roadmaps and the systems engineers actually run, and in what the cloud bill looks like once the free credits expire.
All stories by Yusuf Demir (294)